Shifting the Paradigm: A New Era for Parkinson’s Care
November 3, 2025 | Hear from her, Women in Leadership, podcast
In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.
Padma Mahant, MD, was working in a clinic as a movement disorder specialist when she noticed a disturbing trend. Patients eventually diagnosed with Parkinson’s disease “took several years to find their way to me,” she says. There were many misdiagnoses and multiple medication trials before finally getting correctly diagnosed. And during that elapsed time, their Parkinson’s had progressed quite a bit. “It seemed like such a lost opportunity for early intervention,” Mahant says, “because we know from studies that starting treatment early can improve quality of life and slow the disease’s progression significantly.”
Listen to the full episode here
That realization was a turning point in Mahant’s career. She decided she wanted to become involved in educating clinicians about Parkinson’s symptoms during the “significant prodromal state prior to developing motor symptoms” and researching and creating a diagnostic tool for clinicians to use.
Mahant still sees patients, but now she’s also Director of Medical Affairs at CND Life Sciences, a company leading the way in advancing the care of patients facing a potential diagnosis of a neurodegenerative disease. And they have made breakthroughs: CND recently presented a sleep study that revealed a particular protein detected in 75% of Parkinson’s patients with Rapid Eye Movement Sleep Behavior Disorder but no motor symptoms. Manant says she believes “this is an opportunity to really move the needle” in terms of early intervention and towards disease modification.
Before her big career pivot, Mahant says, “one of the first people I called to say, ‘Hey, I’m thinking about making this shift and what do you think?’ Was Indu.”
Indu is Dr. Indu Subramanian, clinical professor of neurology at UCLA and director of the South West Parkinson Disease Research, Education and Clinical Care Center of Excellence. She is also board certified in Integrative medicine and co-chair of the Wellness Task Force at the Movement Disorders Society. “As a young neurologist, I found that classic Western medicine wasn’t really serving my patients that well. So I became curious about other things,” she says.
Subramanian started her own yoga and mindfulness practices and ended up training to teach both. She also became interested in integrative medicine and alternative practices like Ayurveda and traditional Chinese medicine, and started really leaning into those things for her Parkinson’s patients, to help with the emotional distress that Parkinson’s can cause.
Listen to the full episode here
The image most people have of Parkinson’s, Subramanian says, is an older Caucasian man with a tremor. However, a growing body of evidence, and the stories of countless patients, challenges this outdated view. Changing the Parkinson’s narrative, especially for women, requires not just better science, but also raising awareness about prodromal symptoms and the need for clinicians to be more proactive about early diagnosing.
Women in a prodromal stage, for instance, often experience anxiety and constipation, but are often told their symptoms are stress-related. Once patients understand that they are experiencing Parkinson’s type symptoms, we can teach them wellness strategies and lifestyle changes to help them live better, they say. “Hopefully, developing those strategies early can help prevent progression.”
“I think we all went into medicine to help make other people’s lives better,” says Subramanian. “What fills my teacup time and time again is helping a patient and hearing that they’re doing better because of something that I was able to bring, uniquely as a woman perhaps. Who was able to slow down and take the time and connect, offer them something to help them feel better other than a pill or surgery.”
Hosted by Sara Thorpe, Director of Clinical Strategy at Medscape Education
Follow us on LinkedIn for updates on upcoming podcasts and more insightful conversations.
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professionals.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Shining a Light on Current Topics in Oncology
The Medscape Oncology team will be on the road again, this time in Madrid, Spain for ESMO 2023. This year, the team will be sharing education with a deep impact...
Disseminating Outcomes and Impact in Berlin
The Medscape Education Global team is looking forward to a busy time in Berlin at the EADV Congress 2023. During the congress, Medscape will be presenting five posters examining the...
Medscape Education’s Large Presence at IDWeek 2023
Medscape are powering education and disease state awareness in infectious diseases at #IDWeek 2023
Contagious Conversations: Exploring Infectious Disease in the Digital Age
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Impacting Lives with Rare Disease Education
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...
Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...
A Rare Disease Update from Medscape Education
A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency
New Outcomes Are a Breath of Fresh Air at ERS
ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...
Medscape Education Launches 20th Older Driver Safety Educational Program
Education Supported by the National Highway Traffic Safety Administration